Skip to content

OTC FOCUS: what changed

Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.

What changed

OTC FOCUS

BE 0867.755.466
NACE 46.460, Wholesale of pharmaceutical and medical goods
fiscal year 2023 against 2024filed annual accounts (NBB)
Net result for the year
€108
2023 · €60+€48
Equity
€20,186
2023 · €20,078+€108
Cash
-
not filed
Balance sheet total
€27,302
2023 · €27,152+€149

Largest movements

2023 to 2024
Assets

No asset line moved by more than 1% of the balance sheet total.

    Equity and liabilities

    No liability line moved by more than 1% of the balance sheet total.

      Income statement
      • Gross operating margin +€353

        up €353 (+44.0%), from -€802 to -€449

      • Financial income -€191

        down €191 (-10.8%), from €1,767 to €1,576

      • Financial charges +€88

        up €88 (+9.8%), from €890 to €978

      • Taxes +€27

        up €27 (+188.5%), from €14 to €41

      From the 2023 result to the 2024 result

      effect on the result

      Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.

      Result 2023 €60
      Gross operating margin +€353
      Financial income -€191
      Financial charges -€88
      Taxes -€27
      Result 2024 €108

      Cash bridge derived

      cash 2023 to 2024

      Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.

      Every line side by side 33 lines
      Line Code 2023 2024 Change %
      Total assets 20/58 €27,152 €27,302 +€149 +0.5%
      Fixed assets 21/28 €124 €124 = 0.0%
      Financial fixed assets 28 €124 €124 = 0.0%
      Current assets 29/58 €27,028 €27,177 +€149 +0.6%
      Amounts receivable within one year 40/41 €27,028 €27,177 +€149 +0.6%
      Trade receivables 40 €1,235 €1,235 = 0.0%
      Other amounts receivable 41 €25,793 €25,942 +€149 +0.6%
      Total equity and liabilities 10/49 €27,152 €27,302 +€149 +0.5%
      Equity 10/15 €20,078 €20,186 +€108 +0.5%
      Contributions 10/11 €12,500 €12,500 = 0.0%
      Reserves 13 €1,860 €1,860 = 0.0%
      Non-distributable reserves 130/1 €1,860 €1,860 = 0.0%
      Other 1319 €1,860 €1,860 = 0.0%
      Profit (loss) carried forward 14 €5,718 €5,826 +€108 +1.9%
      Amounts payable 17/49 €7,074 €7,115 +€41 +0.6%
      Amounts payable within one year 42/48 €7,074 €7,115 +€41 +0.6%
      Financial debts 43 €4,774 €4,774 +€0 0.0%
      Credit institutions 430/8 €4,774 €4,774 +€0 0.0%
      Trade debts 44 €2,263 €2,263 = 0.0%
      Suppliers 440/4 €2,263 €2,263 = 0.0%
      Taxes, remuneration and social security 45 €14 €55 +€41 +288.5%
      Taxes 450/3 €14 €55 +€41 +288.5%
      Other amounts payable 47/48 €23 €23 = 0.0%
      Gross operating margin 9900 -€802 -€449 +€353 +44.0%
      Operating profit (loss) 9901 -€802 -€449 +€353 +44.0%
      Financial income 75/76B €1,767 €1,576 -€191 -10.8%
      Recurring financial income 75 €1,767 €1,576 -€191 -10.8%
      Financial charges 65/66B €890 €978 +€88 +9.8%
      Recurring financial charges 65 €890 €978 +€88 +9.8%
      Profit (loss) for the period before taxes 9903 €74 €149 +€74 +99.9%
      Income taxes 67/77 €14 €41 +€27 +188.5%
      Profit (loss) for the period 9904 €60 €108 +€48 +79.2%
      Profit (loss) for the period to be appropriated 9905 €60 €108 +€48 +79.2%

      Source: filed annual accounts (NBB), fiscal years ended 31 December 2023 and 31 December 2024. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 3 October 2026 via checked.be.